We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00431080
Recruitment Status : Completed
First Posted : February 5, 2007
Last Update Posted : January 21, 2008
University Hospital of Crete
Information provided by:
Hellenic Oncology Research Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2007
  Study Completion Date : October 2007